BIOCON
Quarterly Results Analysis [Jun2025]
BIOCON Quarterly Results
Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹3,942 Cr | ₹4,417 Cr | ₹3,821 Cr | ₹3,590 Cr | ₹3,433 Cr | ₹3,917 Cr | ₹3,954 Cr | ₹3,462 Cr |
Expenses | ₹3,193 Cr | ₹3,339 Cr | ₹3,070 Cr | ₹2,905 Cr | ₹2,813 Cr | ₹3,001 Cr | ₹3,027 Cr | ₹2,721 Cr |
Operating Income | ₹749 Cr | ₹1,078 Cr | ₹752 Cr | ₹685 Cr | ₹620 Cr | ₹916 Cr | ₹927 Cr | ₹742 Cr |
Other Income | ₹80 Cr | ₹37 Cr | ₹35 Cr | ₹33 Cr | ₹1,135 Cr | ₹49 Cr | ₹566 Cr | ₹158 Cr |
Interest | ₹277 Cr | ₹212 Cr | ₹223 Cr | ₹226 Cr | ₹236 Cr | ₹227 Cr | ₹267 Cr | ₹248 Cr |
Depreciation | ₹455 Cr | ₹436 Cr | ₹425 Cr | ₹420 Cr | ₹405 Cr | ₹407 Cr | ₹415 Cr | ₹389 Cr |
Profit Before Tax | ₹97 Cr | ₹487 Cr | ₹156 Cr | ₹98 Cr | ₹1,146 Cr | ₹322 Cr | ₹832 Cr | ₹239 Cr |
Profit After Tax | ₹89 Cr | ₹459 Cr | ₹81 Cr | ₹27 Cr | ₹862 Cr | ₹226 Cr | ₹777 Cr | ₹197 Cr |
EPS | ₹0.23 | ₹2.87 | ₹0.21 | ₹-0.13 | ₹5.49 | ₹1.13 | ₹5.50 | ₹1.05 |
Industry Peers & Returns | 1W | 1M | 1Y |
BIOCON | 0.9% | 1.2% | -9.3% |
SUN PHARMACEUTICAL INDUSTRIES | 2% | 1.4% | -13% |
DIVIS LABORATORIES | 1.3% | 0.3% | 10.4% |
CIPLA | 0.3% | 1.9% | -6.1% |
TORRENT PHARMACEUTICALS | 0% | -2.3% | 2.6% |
DR REDDYS LABORATORIES | 0.5% | 6.2% | -1.4% |
MANKIND PHARMA | 2.3% | 5.9% | 4.6% |
ZYDUS LIFESCIENCES | 0.3% | 6% | -7.2% |
LUPIN | 0.2% | 4% | -9.8% |
BIOCON Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -10.76 % |
Y-o-Y | 14.83 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹3,942 Cr | -10.76 | |
Mar2025 | ₹4,417 Cr | 15.59 | |
Dec2024 | ₹3,821 Cr | 6.43 | |
Sep2024 | ₹3,590 Cr | 4.59 | |
Jun2024 | ₹3,433 Cr | -12.36 | |
Mar2024 | ₹3,917 Cr | -0.93 | |
Dec2023 | ₹3,954 Cr | 14.19 | |
Sep2023 | ₹3,462 Cr | - |
BIOCON Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -30.54 % |
Y-o-Y | 20.71 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹749 Cr | -30.54 | |
Mar2025 | ₹1,078 Cr | 43.42 | |
Dec2024 | ₹752 Cr | 9.69 | |
Sep2024 | ₹685 Cr | 10.48 | |
Jun2024 | ₹620 Cr | -32.26 | |
Mar2024 | ₹916 Cr | -1.18 | |
Dec2023 | ₹927 Cr | 24.97 | |
Sep2023 | ₹742 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -22.16 % |
Y-o-Y | 5.15 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 19% | -22.16 | |
Mar2025 | 24.41% | 24.10 | |
Dec2024 | 19.67% | 3.04 | |
Sep2024 | 19.09% | 5.64 | |
Jun2024 | 18.07% | -22.71 | |
Mar2024 | 23.38% | -0.26 | |
Dec2023 | 23.44% | 9.43 | |
Sep2023 | 21.42% | - |
BIOCON Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -80.58 % |
Y-o-Y | -89.65 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹89 Cr | -80.58 | |
Mar2025 | ₹459 Cr | 466.46 | |
Dec2024 | ₹81 Cr | 199.26 | |
Sep2024 | ₹27 Cr | -96.86 | |
Jun2024 | ₹862 Cr | 282.00 | |
Mar2024 | ₹226 Cr | -70.98 | |
Dec2023 | ₹777 Cr | 294.82 | |
Sep2023 | ₹197 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -78.27 % |
Y-o-Y | -91.00 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 2.26 % | -78.27 | |
Mar2025 | 10.4 % | 390.57 | |
Dec2024 | 2.12 % | 182.67 | |
Sep2024 | 0.75 % | -97.01 | |
Jun2024 | 25.1 % | 335.76 | |
Mar2024 | 5.76 % | -70.70 | |
Dec2023 | 19.66 % | 245.52 | |
Sep2023 | 5.69 % | - |
BIOCON Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -91.99 % |
Y-o-Y | -95.81 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹0.23 | -91.99 | |
Mar2025 | ₹2.87 | 1,266.67 | |
Dec2024 | ₹0.21 | Positive | |
Sep2024 | ₹-0.13 | Negative | |
Jun2024 | ₹5.49 | 385.84 | |
Mar2024 | ₹1.13 | -79.45 | |
Dec2023 | ₹5.5 | 423.81 | |
Sep2023 | ₹1.05 | - |
You may also like the below Video Courses